TAT-NR2B9C is a synthetic peptide fusion of the nine C-terminal residues of the NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor and the cell membrane protein transduction domain of the HIV-1 tat protein. It is a postsynaptic density protein-95 (PSD95) inhibitor with neuroprotective properties. It is under development for the treatment of acute stroke and acute cerebral ischemia.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/31213815
Curator's Comment: Low brain penetrability.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. | 2007 Sep 12 |
|
Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat. | 2017 Jan |
|
Discovery and development of NA-1 for the treatment of acute ischemic stroke. | 2018 May |
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 09:40:24 GMT 2023
by
admin
on
Sat Dec 16 09:40:24 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
D45TI2TWMA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
377812
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
||
|
FDA ORPHAN DRUG |
412713
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C170212
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
10857
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
D45TI2TWMA
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
GH-179
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
500992-11-0
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
DB12595
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY | |||
|
44568939
Created by
admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
neurological agent
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|